CO5021227A1 - Azoles hidrosolubles como antifungicos de amplio espectro - Google Patents
Azoles hidrosolubles como antifungicos de amplio espectroInfo
- Publication number
- CO5021227A1 CO5021227A1 CO99029778A CO99029778A CO5021227A1 CO 5021227 A1 CO5021227 A1 CO 5021227A1 CO 99029778 A CO99029778 A CO 99029778A CO 99029778 A CO99029778 A CO 99029778A CO 5021227 A1 CO5021227 A1 CO 5021227A1
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- radical
- amino
- hydroxy
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Un compuesto de la fórmulaUna forma de N-óxido, una sal de adición farmacéuticamente aceptable o una forma estereisómericamente posible del mismo, en el cual L representa un radical de la fórmula en la cual cada Alk representa independientemente alcanodiilo C1-6 optativamente sustituido con hidroxi o alquiloxi C1-4 ;cada n es independientemente 1, 2 ó 3; Y representa O, S o NR2 ; cada R1 representa independientemente hidrógeno, arilo, Het1 o alquilo C1-6 optativamente sustituido con uno, dos o tres sustituyentes cada uno de los cuales es independientemente seleccionado entre halo, hidroxi, mercapto, alquiloxi C1-4 , alquiltio C1-4 , ariloxi, ariltio, arilalquiloxi C1-4 , arilalquiltio C1-4 , ciano, amino, mono- o di(alquilo C1-4 )-amino, mono- o di(aril)amino, mono- o di(arilalquilC1-4 )amino, alquiloxicarbonilamino C1-4 , benciloxicarbonilamino, aminocarbonilo, carboxilo, alquiloxicarbonilo C1-4 , guanidinilo, arilo o Het2 ; Cada R2 independientemente representa hidrógeno o alquilo C1-6 , o en el caso en que R1 y R2 están unidos al mismo átomo de nitrógeno pueden tomarse juntos para formar un radical heterocíclico seleccionado entre morfolinilo, pirrolidinilo, piperidinilo, homopiperidinilo o piperazinilo; dicho radical heterocíclico puede estar optativamente sustituido con alquilo C1-4 , arilo, Het2 , arilalquilo C1-4 , Het2 alquilo C1-4 , - 2 -hidroxialquilo C1-4 , amino, mono- o di(alquilo C1-4 )amino, aminoalquilo C1-4 , mono- o di(alquil C1-4 )aminoalquilo C1-4 , carboxilo, aminocarbonilo, alquiloxicarbonilo C1-4 , alquiloxicarbonilamino C1-4 o mono- o di(alquil C1-4 )aminocarbonilo o Pueden tomarse juntos para formar un radical azido; Cada R3 representa independientemente hidrógeno, hidroxi o alquiloxi C1-4 ; arilo representa fenilo, naftalenilo, 1,2,3,4-tetrahidro-naftalenilo, indenilo o indanilo; cada uno de dichos grupos arilo puede estar optativamente sustituido con uno o más sustituyentes seleccionados entre halo, alquilo C1-4 , hidroxi, alquiloxi C1-4 , nitro amino, trifluorometilo, hidroxialquilo C1-4 , alquiloxiC1-4 alquilo C1-4 , aminoalquilo C1-4 , mono- o di(alquil C1-4 )aminoalquilo C1-4 ,HET1 representa un radical heterocíclico monocíclico o bicíclico; radical heterocíclico monocíclico que es seleccionado entre el grupo que consiste en piridinilo, piperidinilo, homopiperidinilo, pirazinilo, pirimidinilo, piridazinilo, triazinilo, triazolilo, piranilo, tetrahidropiranilo, imidazolilo, imidazolinilo, imidazolidinilo, pirazolilo, pirazolinilo, pirazolidinilo, tiazolilo, tiazolidinilo, isotiazolilo, oxazolilo, oxazolidinilo, isoxazolilo, pirrolilo, pirrolinilo, pirrolidinilo, furanilo, tetrahidrofuranilo, tienilo, tiolanilo, dioxolanilo, y dicho radical heterociclo bicíclico puede ser seleccionado entre el grupo que consiste en quinolinilo, 1,2,3,4AND#8209; tetrahidroquinolinilo, isoquinolinilo, quinoxalinilo, quinazolinilo, ftalazinilo, cinolinilo, cromannilo, tiocromanilo, 2HAND#8209;cromenilo, 1,4AND#8209;benzodioxanilo, indolilo, isoindolilo, indolinilo, indazolilo, purinilo, pirrolopiridinilo, furanopiridinilo, tienopiridinilo, benzotiazolilo, banzoxazolilo, bencisotiazolilo, bencisoxazolilo, bencimidazolilo, Benzofuranilo, benzotienilo; por lo cual cada uno de dichos heterociclos monoAND#8209; o bicíclicos puede estar optativamente sustituido con uno o, en lo posible, más sustituyentes seleccionados entre el grupo que consiste en halo, alquilo C1AND#8209;4 , hidroxi, alquiloxi C1AND#8209;4 , nitro, amino, trifluorometilo, hidroxialquilo C1AND#8209;4 , alquiloxiC1-4 alquilo C1-4 , aminoalquilo C1-4 , monoAND#8209; o di(alquil C1-4 )aminoalquilo C1-4 , arilo o arilalquilo C1-4 , Het2 es igual a Het1 y también puede ser un heterociclo monocíclico seleccionado entre el grupo que consiste en piperazinilo, homopiperazinilo, 1,4AND#8209;dioxanilo, morfolinilo, tiomorfolinilo; por lo cual cada uno de dichos heterociclos monocíclicos puede estar optativamente sustituido con uno o, en lo posible, más sustituyentes seleccionados entre el grupo que consiste en halo, alquilo C1-4 , hidroxi, alquiloxi C1AND#8209;4 , nitro, amino, trifluorometilo, hidroxialquilo C1-4 , alquiloxiC1-4 alquilo C1-4 , aminoalquilo C1-4 , monoAND#8209; o di(alquil C1-4 ,) aminoalquilo C1AND#8209;4 , arilo o arilalquilo C1AND#8209;4 , R6 representa hidrógeno o alquilo C1-4 R7 representa hidrógeno o alquilo C1-4 o R6 y R7 juntos forman un radical bivalente de la fórmula AND#8209;R6 AND#8209;R7 AND#8209;en la cualAND#8209;R6 AND#8209;R7 AND#8209; es: AND#8209;N=CHAND#8209; (i), AND#8209;CH=NAND#8209; (ii), AND#8209;CH=CHAND#8209; (iii), AND#8209;CH2 AND#8209;CH2 AND#8209; (iv),donde un átomo de hidrógeno de los radicales (i) y (ii) puede ser reemplazado con un radical alquilo C1-4 , y uno o más átomos de hidrógeno de los radicales (iii) y (iv) pueden ser reemplazados con un radical alquilo C1-4 ; D representa un radical de la fórmula En la cual X es N o CH; R4 es hidrógeno o halo; R5 es halo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98201588A EP0957101A1 (en) | 1998-05-14 | 1998-05-14 | Water soluble azoles as broad-spectrum antifungals |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5021227A1 true CO5021227A1 (es) | 2001-03-27 |
Family
ID=8233724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO99029778A CO5021227A1 (es) | 1998-05-14 | 1999-05-13 | Azoles hidrosolubles como antifungicos de amplio espectro |
Country Status (32)
Country | Link |
---|---|
US (2) | US6384030B1 (es) |
EP (3) | EP0957101A1 (es) |
JP (2) | JP2002514646A (es) |
KR (2) | KR100593395B1 (es) |
CN (2) | CN1137118C (es) |
AR (2) | AR016482A1 (es) |
AT (2) | ATE238296T1 (es) |
AU (2) | AU751135B2 (es) |
BG (2) | BG64388B1 (es) |
BR (2) | BR9911057A (es) |
CA (2) | CA2331187C (es) |
CO (1) | CO5021227A1 (es) |
CZ (2) | CZ298702B6 (es) |
DE (2) | DE69902461T2 (es) |
DK (1) | DK1077976T3 (es) |
EE (2) | EE04311B1 (es) |
ES (2) | ES2198915T3 (es) |
HK (2) | HK1033312A1 (es) |
HR (2) | HRP20000741B1 (es) |
HU (2) | HUP0103536A3 (es) |
IL (2) | IL139649A (es) |
MY (2) | MY122147A (es) |
NO (2) | NO319851B1 (es) |
NZ (2) | NZ507965A (es) |
PL (2) | PL194085B1 (es) |
PT (1) | PT1077976E (es) |
SI (1) | SI1077976T1 (es) |
SK (2) | SK286156B6 (es) |
TR (2) | TR200003323T2 (es) |
TW (2) | TWI259835B (es) |
WO (2) | WO1999058530A1 (es) |
ZA (2) | ZA200007173B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0957101A1 (en) * | 1998-05-14 | 1999-11-17 | Janssen Pharmaceutica N.V. | Water soluble azoles as broad-spectrum antifungals |
AU3402301A (en) * | 2000-03-07 | 2001-09-17 | Ranbaxy Laboratories Limited | Azole compounds as therapeutic agents for fungal infections |
EP1413301A1 (fr) * | 2002-10-24 | 2004-04-28 | Bayer CropScience SA | Médicaments antifongiques à base de dérivés d'arylamidine |
ITMI20032020A1 (it) * | 2003-10-17 | 2005-04-18 | Italfarmaco Spa | Nuovi agenti antifungini azolici con diminuita interazione con i citocromi metabolici |
AR052342A1 (es) * | 2004-12-21 | 2007-03-14 | Janssen Pharmaceutica Nv | Derivados sustituidos de triazolona,tetrazolona e imidazolona con actividad selectiva antagonista de alfa2c-adenoreceptores |
WO2011144653A1 (en) * | 2010-05-19 | 2011-11-24 | Sandoz Ag | Process for the preparation of chiral triazolones |
US11028078B2 (en) * | 2011-09-07 | 2021-06-08 | The Johns Hopkins University | Itraconazole analogs and use thereof |
US9346791B2 (en) | 2011-09-07 | 2016-05-24 | The Johns Hopkins University | Itraconazole analogs and use thereof |
US9663499B2 (en) * | 2013-06-07 | 2017-05-30 | The California Institute For Biomedical Research | Small molecule inhibitors of fibrosis |
WO2016087878A1 (en) | 2014-12-05 | 2016-06-09 | Pulmocide Limited | Antimycotic compound |
WO2016094570A1 (en) * | 2014-12-10 | 2016-06-16 | The California Institute For Biomedical Research | Small molecule inhibitors of fibrosis |
DK3298006T3 (da) | 2015-05-21 | 2020-03-30 | Pulmocide Ltd | Antifungal 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorphenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl)piperazin-1-yl)-n-(2-hydroxycyclohexyl)benzamid eller et farmaceutisk acceptabelt salt deraf |
CN105237392B (zh) * | 2015-11-24 | 2017-12-12 | 辽宁渤大化工有限公司 | 芳烷基水杨酸及其衍生物的制备方法 |
AU2018321287A1 (en) | 2017-08-20 | 2020-04-02 | University Of Connecticut | Azole analogues and methods of use thereof |
CN111138421A (zh) * | 2019-12-26 | 2020-05-12 | 上海英诺富成生物科技有限公司 | 抗真菌水溶性化合物及其制备方法与应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4218458A (en) * | 1978-06-23 | 1980-08-19 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
PL172358B1 (en) * | 1992-03-18 | 1997-09-30 | Janssen Pharmaceutica Nv | Stereoisomeric form of itraconazole or saperconazole and method of obtaining same |
AU681753B2 (en) * | 1993-12-21 | 1997-09-04 | Merck Sharp & Dohme Corp. | Tetrahydrofuran antifungals |
NZ278882A (en) * | 1994-01-24 | 1997-06-24 | Janssen Pharmaceutica Nv | Piperazine-containing azole antifungal compounds |
FI98688C (fi) * | 1994-07-20 | 1997-07-25 | Nokia Telecommunications Oy | Menetelmä lyhytsanomalähetyksen käynnistämiseksi solukkoradiojärjestelmässä, solukkoradiojärjestelmä sekä solukkoradiojärjestelmän tilaajarekisteri |
ATE240319T1 (de) * | 1995-06-02 | 2003-05-15 | Schering Corp | Antifungale tetrahydrofurane |
WO1997000255A1 (en) * | 1995-06-19 | 1997-01-03 | Schering Corporation | Tetrahydrofuran antifungals |
DE69824834T2 (de) | 1997-02-11 | 2005-07-21 | Janssen Pharmaceutica N.V. | Azole enthaltende antifungale aminosäure-ester |
EP0957101A1 (en) * | 1998-05-14 | 1999-11-17 | Janssen Pharmaceutica N.V. | Water soluble azoles as broad-spectrum antifungals |
-
1998
- 1998-05-14 EP EP98201588A patent/EP0957101A1/en not_active Withdrawn
-
1999
- 1999-05-06 WO PCT/EP1999/003243 patent/WO1999058530A1/en active IP Right Grant
- 1999-05-06 PT PT99926304T patent/PT1077976E/pt unknown
- 1999-05-06 IL IL13964999A patent/IL139649A/en not_active IP Right Cessation
- 1999-05-06 EP EP99924942A patent/EP1077975B1/en not_active Expired - Lifetime
- 1999-05-06 JP JP2000548334A patent/JP2002514646A/ja active Pending
- 1999-05-06 SK SK1681-2000A patent/SK286156B6/sk not_active IP Right Cessation
- 1999-05-06 AU AU41417/99A patent/AU751135B2/en not_active Ceased
- 1999-05-06 EP EP99926304A patent/EP1077976B1/en not_active Expired - Lifetime
- 1999-05-06 ES ES99924942T patent/ES2198915T3/es not_active Expired - Lifetime
- 1999-05-06 DE DE69902461T patent/DE69902461T2/de not_active Expired - Lifetime
- 1999-05-06 PL PL99344047A patent/PL194085B1/pl unknown
- 1999-05-06 IL IL13964799A patent/IL139647A0/xx not_active IP Right Cessation
- 1999-05-06 TR TR2000/03323T patent/TR200003323T2/xx unknown
- 1999-05-06 WO PCT/EP1999/003242 patent/WO1999058529A1/en active IP Right Grant
- 1999-05-06 AT AT99924942T patent/ATE238296T1/de not_active IP Right Cessation
- 1999-05-06 CZ CZ20004109A patent/CZ298702B6/cs not_active IP Right Cessation
- 1999-05-06 CZ CZ20004108A patent/CZ299481B6/cs not_active IP Right Cessation
- 1999-05-06 JP JP2000548333A patent/JP2002514645A/ja active Pending
- 1999-05-06 NZ NZ507965A patent/NZ507965A/en not_active IP Right Cessation
- 1999-05-06 NZ NZ507966A patent/NZ507966A/xx not_active IP Right Cessation
- 1999-05-06 BR BR9911057-1A patent/BR9911057A/pt not_active Application Discontinuation
- 1999-05-06 CA CA002331187A patent/CA2331187C/en not_active Expired - Fee Related
- 1999-05-06 EE EEP200000657A patent/EE04311B1/xx not_active IP Right Cessation
- 1999-05-06 PL PL99344037A patent/PL194086B1/pl unknown
- 1999-05-06 DK DK99926304T patent/DK1077976T3/da active
- 1999-05-06 CA CA002331141A patent/CA2331141C/en not_active Expired - Fee Related
- 1999-05-06 ES ES99926304T patent/ES2182531T3/es not_active Expired - Lifetime
- 1999-05-06 AU AU43615/99A patent/AU758876B2/en not_active Ceased
- 1999-05-06 AT AT99926304T patent/ATE221884T1/de active
- 1999-05-06 CN CNB998059560A patent/CN1137118C/zh not_active Expired - Fee Related
- 1999-05-06 CN CNB998060690A patent/CN1135229C/zh not_active Expired - Fee Related
- 1999-05-06 KR KR1020007009640A patent/KR100593395B1/ko active IP Right Grant
- 1999-05-06 SK SK1682-2000A patent/SK285763B6/sk not_active IP Right Cessation
- 1999-05-06 US US09/700,251 patent/US6384030B1/en not_active Expired - Lifetime
- 1999-05-06 SI SI9930131T patent/SI1077976T1/xx unknown
- 1999-05-06 HU HU0103536A patent/HUP0103536A3/hu unknown
- 1999-05-06 BR BR9910448-2A patent/BR9910448A/pt not_active Application Discontinuation
- 1999-05-06 DE DE69907171T patent/DE69907171T2/de not_active Expired - Lifetime
- 1999-05-06 US US09/700,166 patent/US6448244B1/en not_active Expired - Lifetime
- 1999-05-06 EE EEP200000651A patent/EE04346B1/xx not_active IP Right Cessation
- 1999-05-06 HU HU0102031A patent/HUP0102031A3/hu unknown
- 1999-05-06 KR KR1020007011624A patent/KR100575147B1/ko not_active IP Right Cessation
- 1999-05-06 TR TR2000/03322T patent/TR200003322T2/xx unknown
- 1999-05-10 TW TW088107505A patent/TWI259835B/zh not_active IP Right Cessation
- 1999-05-10 TW TW088107504A patent/TW572899B/zh not_active IP Right Cessation
- 1999-05-11 MY MYPI99001862A patent/MY122147A/en unknown
- 1999-05-11 MY MYPI99001861A patent/MY120248A/en unknown
- 1999-05-13 AR ARP990102276A patent/AR016482A1/es active IP Right Grant
- 1999-05-13 AR ARP990102270A patent/AR016480A1/es active IP Right Grant
- 1999-05-13 CO CO99029778A patent/CO5021227A1/es unknown
-
2000
- 2000-08-28 BG BG104717A patent/BG64388B1/bg unknown
- 2000-11-02 HR HR20000741A patent/HRP20000741B1/xx not_active IP Right Cessation
- 2000-11-02 HR HR20000740A patent/HRP20000740B1/xx not_active IP Right Cessation
- 2000-11-09 BG BG104933A patent/BG64954B1/bg unknown
- 2000-11-13 NO NO20005712A patent/NO319851B1/no not_active IP Right Cessation
- 2000-11-13 NO NO20005713A patent/NO319760B1/no not_active IP Right Cessation
- 2000-12-04 ZA ZA200007173A patent/ZA200007173B/en unknown
- 2000-12-13 ZA ZA200007459A patent/ZA200007459B/xx unknown
-
2001
- 2001-05-19 HK HK01103465A patent/HK1033312A1/xx not_active IP Right Cessation
- 2001-05-19 HK HK01103466A patent/HK1032781A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5021227A1 (es) | Azoles hidrosolubles como antifungicos de amplio espectro | |
RS52431B (en) | QUINOLINE DERIVATIVES AND THEIR USE AS MYCOBACTERIAL INHIBITORS | |
ES2283716T3 (es) | Inhibidores de la replicacion del virus sincitial respiratorio. | |
ES2225231T3 (es) | Compuestos heterociclicos, utiles como inhibidores de tirosina quinasas. | |
ES2593256T3 (es) | Compuestos químicos, composiciones y métodos para las modulaciones de cinasas | |
AR054889A1 (es) | Derivados de quinolina como agentes bacterianos | |
CO5180553A1 (es) | Derivados de pirimidona de la formula (1) o sales de los mismos y medicamentos que contienen dichos derivados como ingrediente activo | |
ES2704704T3 (es) | Nuevos derivados de azaindol como inhibidores selectivos de la histona desacetilasa (HDAC) y composiciones farmacéuticas que los comprenden | |
ES2671502T3 (es) | Proceso novedoso para preparar compuestos para su uso en el tratamiento de cáncer | |
AR048522A1 (es) | Derivados sustituidos de diaza-espiro-(5.5)-undecano y su uso como antagonistas de neuroquininas | |
AR048521A1 (es) | Derivados sustituidos de diaza-espiro-(4.5)-decano y su uso como antagonistas de neuroquininas | |
EA201290520A1 (ru) | Производные дифенилпиразолопиридинов, их получение и применение в качестве модуляторов нуклеарного рецептора not | |
HRP20090294T1 (en) | Derivatives of piperidinylalkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors | |
HRP20080024T3 (en) | Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors | |
ES2226844T3 (es) | Aminoazaciclos heterociclicos sustituidos utiles como agentes activos sobre el sistema nervioso central. | |
WO2011058113A1 (en) | Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors | |
CA2944801C (en) | Analogs of 4h-pyrazolo[1,5-a]benzimidazole compounds as parp inhibitors | |
WO2010051043A1 (en) | Benzoxazole kinase inhibitors and methods of use | |
NZ334971A (en) | 2-cyanoiminoimidazole derivatives for use as phosphodiesterase (PDE) IV inhibitors | |
NZ586610A (en) | Novel cytostatic 7-deazapurine nucleosides | |
NO20063681L (no) | Aryloksyalkylkarbamattype derivater, fremgangsmate for fremstilling derav og anvendelse av derivatene i terapeutiske midler | |
CO6251238A2 (es) | Tetrahidrobenzo-1,4-diacepinas arilo - y heteroarilo - sustituidas y su uso para bloquear la recaptacion de norepinefrina dapamina y serotanina | |
GB1303081A (es) | ||
RU99109032A (ru) | Производные 2-цианоиминоимидазола, ингибирующие pde iv | |
ES2370049T3 (es) | Nuevos derivados de imidazolonas, su preparación como medicamentos, composiciones farmacéuticas, utilización como inhibidores de proteínas quinasas, en particular cdc7. |